Business Description
BioRegenx Inc
NAICS : 923120
SIC : 7372
ISIN : US31772N1000
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | -13.29 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.08 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -26 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 80.04 | |||||
9-Day RSI | 66.46 | |||||
14-Day RSI | 56.88 | |||||
6-1 Month Momentum % | -53.18 | |||||
12-1 Month Momentum % | -22.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.11 | |||||
Quick Ratio | 0.06 | |||||
Cash Ratio | 0.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.1 | |||||
Shareholder Yield % | -10.62 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 69.19 | |||||
Operating Margin % | 163.42 | |||||
Net Margin % | 226.35 | |||||
FCF Margin % | -90.49 | |||||
ROE % | -21.2 | |||||
ROA % | -16.84 | |||||
ROIC % | -11.15 | |||||
ROC (Joel Greenblatt) % | -533.46 | |||||
ROCE % | -20.11 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 3.18 | |||||
PE Ratio without NRI | 3.18 | |||||
PB Ratio | 1.59 | |||||
Price-to-Free-Cash-Flow | 3.18 | |||||
Price-to-Operating-Cash-Flow | 3.18 | |||||
EV-to-EBIT | -8.01 | |||||
EV-to-EBITDA | -89.62 | |||||
EV-to-Revenue | -17.47 | |||||
EV-to-FCF | 20.26 | |||||
Price-to-Projected-FCF | 1.59 | |||||
Earnings Yield (Greenblatt) % | -12.48 | |||||
FCF Yield % | 4.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BRGX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BioRegenx Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | -0.831 | ||
EPS (TTM) ($) | 0.005 | ||
Beta | -3.23 | ||
Volatility % | 156.76 | ||
14-Day RSI | 56.88 | ||
14-Day ATR ($) | 0.001646 | ||
20-Day SMA ($) | 0.013365 | ||
12-1 Month Momentum % | -22.65 | ||
52-Week Range ($) | 0.0101 - 0.085 | ||
Shares Outstanding (Mil) | 956.53 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BioRegenx Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BioRegenx Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
BioRegenx Inc Frequently Asked Questions
What is BioRegenx Inc(BRGX)'s stock price today?
When is next earnings date of BioRegenx Inc(BRGX)?
Does BioRegenx Inc(BRGX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |